1. Home
  2. RLAY

RLAY

Relay Therapeutics Inc.

Logo Relay Therapeutics Inc.

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Nasdaq

as 04-23-2024 2:08pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).

Founded: 2015 Country:
United States
United States
Employees: N/A City: CAMBRIDGE
Market Cap: 935.3M IPO Year: 2020
Target Price: $23.30 AVG Volume (30 days): 1.2M
Analyst Decision: Strong Buy Number of Analysts: 5
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -2.79 EPS Growth: N/A
52 Week Low/High: $5.95 - $18.67 Next Earning Date: 05-02-2024
Revenue: $25,546,000 Revenue Growth: 1749.82%
Revenue Growth (this year): -99.2% Revenue Growth (next year): 5223.53%

Share on Social Networks: